UPDATE : Thursday, October 17, 2019
상단여백
Pfizer’s leukemia therapy Besponsa to get insurance benefit by Kim Yun-mi 2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients' by Lee Han-soo 2019-09-25 17:39
Huons, Lipac Oncology to co-develop bladder cancer treatment by Lee Han-soo 2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor by Lee Han-soo 2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment by Lee Han-soo 2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study by Lee Han-soo 2019-09-24 17:00
Why using end-to-end services should be part of a drug product strategy by Lee Han-soo 2019-09-24 16:54
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment by Lee Han-soo 2019-09-24 16:38
Hwail, SupexBNP wins patent for neutropenia treatment in US by Lee Han-soo 2019-09-23 22:34
Drug firms uncertain about pricing of quadrivalent flu vaccines by Jeong Sae-im 2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC by Lee Han-soo 2019-09-23 13:28
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’ by Kim Yun-mi 2019-09-23 11:45
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’ by Lee Han-soo 2019-09-20 17:51
Dongwha could lose ₩60 billion sales as GSK ends deal by Lee Han-soo 2019-09-20 14:28
Novo Nordisk releases trial result for basal insulin analog injection by Lee Han-soo 2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea by Lee Han-soo 2019-09-19 17:15
Hanmi unveils strong diabetes pipeline at EU meet by Lee Han-soo 2019-09-19 15:30
‘Galderma Korea ran background checks on unionized workers’ by Jeong Sae-im 2019-09-19 15:18
Takeda Korea labor union to ask Japanese headquarters about restructuring by Kim Yun-mi 2019-09-19 14:11
Chong Kun Dang releases trial result for diabetes treatment by Lee Han-soo 2019-09-19 14:11
여백
여백
여백
Back to Top